7 - 9 December 2008 • Boston, MA, USA

Invited Speakers

The following invited speakers will present at the conference. Additional names are being added to this list – please check back regularly for details.

Jon Andrus, Pan American Health Organization, USA
- Implementing vaccination programs in developing countries

Alan Barrett, University of Texas Medical Branch, USA
- Title to be announced

Dan Barouch, Harvard Medical School, USA
- Novel adenovirus vector-based vaccines for HIV-1

Rich Costantino, Nastech, Inc. USA
- Title to be announced

Dack Dalrymple, Dalrymple & Associates, LLC, USA
- Current & future U.S. Government funding for vaccine R&D and acquisition

Annie de Groot, EpiVax Inc., USA
- Computer-driven vaccine design: From concept to reality

Kate A. Fitzgerald, University of Massachusetts Medical School, USA
- Innate immune pattern recognition receptors and vaccine adjuvants

Hiroshi Kiyono, University of Tokyo, Japan
- Development of self-administrative vaccine by MucoRiceTM System

Dennis Klinman, NCI-Frederick, USA
- Use of CpG oligonucleotides as a vaccine adjuvant

Shan Lu, University of Massachusetts Medical School, SA
- Developing HIV vaccines with protective antibody responses

Adel Mahmoud, Princeton University, USA
- Future of vaccine discovery

Peter Nara, Biological Mimetics Inc, USA
- Improving on Mother Nature's immunogenicity

John S. Oxford, Retroscreen Virology Ltd, UK
- Title to be announced

Gregory A. Poland, Mayo Vaccine Research Group, USA
- Influenza immunization of health care workers: A patient safety imperative

Rino Rappuoli, Novartis Vaccines and Diagnostics, Italy
- Vaccines: A health insurance of the 21st century

Jerald C. Sadoff, Aeras Global TB Vaccine Foundation, USA
- TB vaccine development

Jennifer Schranz, Wyeth Pharmaceuticals, USA
- Pneumococcal conjugate vaccines:  What do we know and what do we need?

John W. Shiver, Merck and Co Inc., USA
- Development of a novel Staphylococcus aureus vaccine based on a conserved protein antigen

Mark K. Slifka, Oregon Health & Science University, USA
- Duration of immunity following vaccination:  How long it can last and how we can make it better

Ray Spier, University of Surrey, UK
- Title to be announced

Raymond Welsh, University of Massachusetts Medical School, USA
- Pathogenic epitopes, heterologous immunity, and vaccine design

Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, USA
- Of mice and men (and dogs): Clinical development of Xenogeneic DNA vaccines for cancer.

Bruce G. Weniger, Centers for Disease Control and Prevention, USA
- Vaccination into or onto the skin:  Advantages, accomplishments, actualizations, and adumbrations of the cutaneous route

Venue
Venue: the Westin Boston Waterfront
Westin Boston Waterfront